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General Information.  NMR spectra were recorded on an Oxford 300 MHz NMR spectrometer running Varian 
VNMR software.  Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane (TMS) 
with reference to internal solvent for 1H NMR and 13C NMR spectra.  Chemical shifts are reported in parts per 
million (ppm) downfield from H3PO4 for 31P NMR spectra.  Multiplicities are abbreviated as follows: singlet (s), 
doublet (d), triplet (t), quartet (q), quintet (quint), septet (sept), multiplet (m), and broad (br).  Analytical thin-layer 
chromatography (TLC) was performed using silica gel 60 F254 precoated plates (0.25 mm thickness) with a 
fluorescent indicator.  Visualization was performed with standard potassium permanganate stains or UV light.  
Flash column chromatography of organic compounds was performed using silica gel 60 (230-400 mesh), and 
flash column chromatography of ruthenium compounds was performed using silica gel 60 (230-400 mesh) from 
TSI Scientific (Cambridge, MA).  All glassware was either oven dried or flame dried, and reactions were done 
under an atmosphere of argon unless otherwise noted.  All organic solvents were dried by passage through 
solvent purification columns containing activated alumina.  All commercial chemicals were used as obtained.  
Catalyst precursors (PCy3)2(Cl)2Ru=CHPh and S10 were gifts from Materia, Inc.   
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Preparation of Catalyst 10 
 For a synthesis of 10, see Ritter, T.; Day, M. W.; Grubbs, R. H. J. Am. Chem. Soc. 2006, 128, 11768. 
Standard activity plots for 10. 
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Conditions (full experimental is given for use of catalyst 12): 0.8 ml of CD2Cl2 total, 0.08 mmol of 5, 0.004 mmol of 
10. The plot is below. 
RCM of 5 with 10 
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The same conditions were used as before: 0.8 ml of CD2Cl2 total, 0.08 mmol of S4, 0.008 mmol of 10. The plot is 
below. 
RCM of S1 with 10 
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The same conditions were used as before: 0.8 ml of CD2Cl2 total, 0.08 mmol of 5, 0.004 mmol of 10. The plot is 
below. 
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RCM of S3 with 10 
 
A portion of this graph is also presented in Ritter, T.; Day, M. W.; Grubbs, R. H. J. Am. Chem. Soc. 2006, 128, 
11768. 
Preparation of Catalyst 11  
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Synthesis of N, N’-Diphenyl-1,2-diaminobenzene. Pd(OAc)2 (86 mg, 0.379 mmol), [t–Bu3PH]BF4 (110 mg, 
0.379 mmol), and NaOt–Bu (1.22 g, 12.7 mmol) were placed in a dry Schlenk flask equipped with a stir bar. The 
flask was evacuated and backfilled twice with argon. Dry toluene (10 mL) was added and the resulting solution 
was degassed by vigorously bubbling argon through the mixture for 30 min. 1,2-Dibromobenzene (0.51 mL, 4.24 
mmol) was added followed by aniline (0.81 mL, 8.91 mmol). The flask was sealed under argon and heated to 110 
ºC for 14 h. The reaction mixture was allowed to cool to rt, then saturated NH4Cl (20 mL) was added under Ar. 
 
S5 
The mixture was transferred to a separatory funnel using 40 mL of Et2O, and then washed with two further 
portions of saturated NH4Cl. The organic layer was dried using MgSO4 and filtered. The solvent was removed and 
the resulting oil was applied to a silica gel column using pentane/CH2Cl2 (2:1) as eluent. Compound S5 (0.92 g, 
84% yield) was isolated as an off-white solid. The spectral data for S5 were consistent with that reported in the 
literature.1 
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Synthesis of N, N’-Diphenylbenzimidazolium chloride. Imidazolium salt S6 was synthesized as previously 
reported.2 Spectral data for S6 were consistent with that reported in the literature. 
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Synthesis of catalyst S7. In the glovebox, benzimidazolium salt S6 (80 mg, 0.26 mmol) was added to a Schlenk 
tube containing dry benzene (6 mL). KOC(CF3)2CH3 (69 mg, 0.31 mmol) was added and the mixture was stirred 
at rt for 60 min. (PCy3)2(Cl)2Ru=CHPh (107 mg, 0.13 mmol) was added to the mixture and then the flask was 
sealed and removed from the glovebox. The reaction mixture was heated at 60 ºC for 5 h. After cooling to rt, the 
mixture was directly applied to a TSI silica gel column and eluted using a pentane/Et2O (5:1) mixture. This yielded 
complex S7 (54 mg, 51% yield) as an unstable, colorless solid that rapidly decomposes in air, yielding a brownish 
oil. 1H NMR (300 MHz, CD2Cl2) δ 19.40 (1H, d, JH–P =  6 Hz), 8.08 (2H, d, J = 8 Hz), 7.74 (2H, t, J = 8 Hz), 7.64–
7.59 (1H, m), 7.46–7.41 (1H, m), 7.36 (2H, s), 7.24–6.94 (11H, m), 2.13–2.01 (3H, m), 1.60–1.56 (15H, m), 1.23–
1.04 (15H, m).  13C NMR (75 MHz, CD2Cl2) δ 151.0, 137.8, 137.1, 133.5 (d, JC–P =  435 Hz), 130.6, 129.9, 129.8, 
                                                      
1 Wenderski, T.; Light, K. M.; Ogrin, D.; Bott, S. G.; Harlan, C. J. Tetrahedron Lett. 2004, 45, 6851.  
2 Huang, W.; Guo, J.; Xiao, Y.; Zhu, M.; Zou, G.; Tang, J. Tetrahedron, 2005, 61, 9783. 
 
S6 
129.5, 129.0, 128.7, 128.6, 128.5, 128.3, 123.6, 123.4, 111.2, 110.1, 32.8 (d, JC–P = 15 Hz), 29.2, 28.0 (d, JC–P = 
10 Hz), 26.6. 31P NMR (121 MHz, CD2Cl2) δ 22.74. HRMS (FAB, C44H53N2PCl2Ru) calc. 812.2367, found 
812.2339. 
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Synthesis of catalyst 11. Ruthenium complex S7 (80 mg, 0.098 mmol) was dissolved in CH2Cl2 (2 mL). 2-
Isopropoxystyrene (16 mg, 0.099 mmol) was added and the mixture was stirred at rt in the presence of air for 4 
days. The solvent was removed and the resulting mixture was applied to a bed of TSI silica gel. Excess styrene 
was eluted using pentane/CH2Cl2 (1:5). Flushing with neat CH2Cl2, followed by solvent removal yielded catalyst 11 
(48 mg, 83% yield) as a greenish-brown solid. 1H NMR (300 MHz, CD2Cl2) δ 16.64 (1H, s), 8.29 (2H, br m), 7.91 
(2H, br m), 7.68 (5H, br m), 7.62–7.56 (2H, m), 7.25 (4H, br m), 7.02–6.91 (3H, br m), 5.11 (1H, septet, JH–H = 6 
Hz), 1.60 (6H, d, JH–H = 6 Hz).  13C NMR (75 MHz, CD2Cl2) 130.4, 122.9, 122.1, 113.5, 109.7, 75.7, 22.2 (carbon 
resonances for the N-heterocyclic carbene ligand were not observed due to poor signal to noise and line 
broadening resulting from slow exchange). HRMS (FAB, C29H26N2OCl2Ru) calc. 590.0466, found 590.0452. Single 
crystals of catalyst 11, suitable for crystallographic analysis, were grown by slow evaporation from a 
CH2Cl2/benzene solution of 11. CCDC 605939. 
 
 
Standard Plots for 11. 
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The same conditions were used as before: 0.8 ml of CD2Cl2 total, 0.08 mmol of 5, 0.004 mmol of 11. The plot is 
below.  
RCM of 5 with 11 at 30 °C 
 
 
 
O
OEt
O
EtO
O
OEt
O
EtO
S1 S2
11 (1 mol%)
0.1M, CD2Cl2, 30 °C
 
The same conditions were used as before: 0.8 ml of CD2Cl2 total, 0.08 mmol of S4, 0.008 mmol of 11. The plot is 
below.  
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RCM of S1 with 11 at 30 °C 
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The same conditions were used as before: 0.8 ml of CD2Cl2 total, 0.08 mmol of 5, 0.004 mmol of 11. The plot is 
below. 
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RCM of S3 with 11 at 30 °C 
 
 
 
Preparation of catalyst 12. 
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Preparation of diamine S8.  This is a two step procedure. 
N,N’-Bis(3,5-di-t-butylphenyl) oxamide.  Oxalyl chloride (2.16 mL, 25 mmol) was added dropwise to a 
stirred solution of  3,5-di-t-butylaniline (10.28 g, 50 mmol) and triethylamine (7.0 mL, 50 mmol) in THF (200 mL) at 
0 oC. Upon addition, the reaction was allowed to warm up to r.t. and stirred for 1 h.  The reaction mixture was then 
concentrated in vacuo and diluted with water (100 mL).  The white precipitate was collected by filtration, washed 
 
S10 
with dilute HCl (100 mL), water (2x100 mL), and dried in vacuo.  Obtained 9.07 g (78%) of N,N’-Bis(3,5-di-t-
butylphenyl) oxamide as a white solid. 
N,N’-Bis(3,5-di-t-butylphenyl)ethylenediamine (S8).  A 1M solution of BH3-THF in THF (125 mL, 125 
mmol) was added dropwise with stirring to the solid oxamide (9.06 g, 19.52 mmol) at r.t. The resulting 
homogeneous mixture was then refluxed for 15 h, allowed to cool down to r.t. and carefully quenched by adding 
water.  The mixture was then concentrated and extracted with ether. Column chromatography (2:1 hexanes – 
dichloromethane, silica gel) afforded 6.51 g (76%) of pure S8 as a colorless oil and 1.27 g of impure S8 
(contaminated with 3,5-di-t-butylaniline) which was subjected to a second chromatographic purification. The 
combined yield of S8 was 86%.  1H NMR (300 MHz, CDCl3) δ 6.85 (2H, t, J = 1.5 Hz), 6.55 (4H, d, J = 1.8 Hz), 
5.31 (2H, s), 3.45 (4H, s), 1.31 (36H, s); 13C (75 MHz, CDCl3) δ 152.1, 147.8, 112.8, 107.9, 44.1, 35.1, 31.7; 
HRMS (EI+) calc for C30H49N2, 437.3896. Found 437.3902. 
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Preparation of diamine salt S9. Triethyl orthoformate (150 mL) was added to a mixture of S1 (6.51 g, 14.93 
mmol) and ammonium tetrafluoroborate (1.57 g, 14.93 mmol) in a 250-mL r.b. flask.  The flask was equipped with 
a distillation head and heated for about 1 h, during which ethanol distilled over at 78-80 oC, followed by about 70 
mL of triethyl orthoformate at 135-140 oC.  Upon cooling, S9 precipitated as white needles. The precipitate was 
collected by filtration, washed with hexanes and dried in vacuo to afford 7.9 g of S9 (>90%) containing a small 
amount of triethyl orthoformate in the crystal lattice.  Dissolving this crude product in a minimal amount of 
dichloromethane and adding diethyl ether afforded pure S9. 1H NMR (300 MHz, CDCl3) δ 8.57 (1H, s), 7.42 (2H, t, 
J = 1.5 Hz), 7.23 (4H, d, J = 1.8 Hz), 4.69 (4H, s), 1.32 (36H, s); 13C (75 MHz, CDCl3) δ 153.6, 151.4, 135.4, 
123.1, 114.9, 50.5, 35.4, 31.5. HRMS (EI+) calc for C31H47N2, 447.3739, found 447.3729. 
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Catalyst 12.  Diamine salt S9 (156 mg, .3 mmol), KOt-Bu(F6) (66 mg, .3 mmol), and ruthenium complex S10 (132 
mg, .22 mmol) were all combined in toluene in a glove box.  The flask was removed and stirred at 60 °C for 18 
hours in a fume hood.  The reaction mixture was then directly purified by flash column chromatography (5% 
Et2O/Hexanes, run 2 times) to yield catalyst 12 (34 mg, 20%) as a green oil.  The catalyst was then lyophilized 
from benzene to give a pale green solid.  It should be noted that by 1H NMR the conversion to 12 is 50%.  1H 
NMR (300 MHz, CDCl3) δ 16.91 (1H, s), 8.14-8.13 (2H, m), 7.73 (2H, m), 7.64 (1H, m), 7.52 (1H, m), 7.06-6.92 
(2H, m), 6.62 (1H, t, J = 7.5 Hz), 6.31 (1H, d, J = 8.4 Hz), 4.47 (1H, quint, J = 6 Hz), 3.51 (4H, s), 1.51 (18H, s), 
1.35 (6H, d, J = 6 Hz), 1.24 (18H, s); HRMS (EI+) calc for C41H58N2OCl2Ru 766.2970. Found 766.3007.   An X-ray 
crystal structure has also been obtained for this structure. 
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CCDC 622049 
 
Standard activity plots for 12.   
 
Preparation of stock solutions.  Catalyst 12 (14 mg) was placed in a 2ml volumetric flask and taken into a glove 
box.  In the glove box, 2ml of CD2Cl2 was added to make stock solution A.  0.44 ml of A was then transferred to 
another 2ml volumetric flask and diluted to 2ml with CD2Cl2 to make stock solution B. 
 
Activity studies.  
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In a glove box, 0.44 ml of stock solution A (3.1 mg of 12, 0.004 mmol) was transferred to a screw cap NMR tube.  
CD2Cl2 (.36 ml) was added and then 5 (21.5 µl, 0.08 mmol).   The NMR tube was sealed, removed from the glove 
box and heated to 30 °C.  A graph of conversion over time follows.  
RCM of 5 with 12 at 30 °C 
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In a glove box, 0.4 ml of stock solution B (0.6 mg of 12, 0.0008 mmol) was transferred to a screw cap NMR tube.  
CD2Cl2 (.4 ml) was added and the NMR tube was sealed and transferred to a 500 MHz NMR which was warmed 
to 30 °C.  The NMR tube was then ejected,  S1 (20.5 µl, 0.08 mmol) was added and the tube was injected for 
data collection.  A graph of conversion over time follows. 
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RCM of S1 with 12 at 30 °C 
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In a glove box, 0.4 ml of stock solution B (0.6 mg of 12, 0.0008 mmol) was transferred to a screw cap NMR tube.  
CD2Cl2 (.4 ml) was added and the NMR tube was sealed and transferred to a 500 MHz NMR which was warmed 
to 30 °C.  The NMR tube was then ejected,  S3 (19.5 µl, 0.08 mmol) was added and the tube was injected for 
data collection.  A graph of conversion over time follows. 
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RCM of S3 with 12  at 30 °C 
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Diamine Salt S24. A solution of 3,5-ditertbutylaniline (3 g, 14.6 mmol) in toluene (5 ml) was added to a solution of 
paraformaldehyde (220 mg, 7.3 mmol) in toluene (5 ml).  The reaction was then stirred at 100 °C for 1.5 hours.  
The reaction was cooled to 40 °C and 6N HCl (1.2 ml, 7.3 mmol) was added. The reaction was stirred for 5 
minutes, glyoxal (837 µl, 7.3 mmol) was added and the reaction was stirred another 5 minutes.  The reaction was 
stirred at 100 °C for 14 hours, cooled to RT and purified by column chromatography (5% MeOH/CH2Cl2) to yield a 
brown foam.  This foam was washed with Et2O to yield 806 mg (23%) of a white solid. 1H NMR (300 MHz, CDCl3) 
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δ 11.89 (br, 1H), 7.78-7.76 (m, 6H), 7.59 (s, 2H), 1.42 (s, 36H); HRMS (EI+) calc for C31H45N2, 445.3583. Found 
445.3561.   
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Ruthenium Catalyst 20.  In a glove box, diamine salt S24 (63 mg, .13 mmol), ruthenium precursor S10 (78 mg,  
.13 mmol) and KOt-Bu(F6) (29 mg, .13 mmol) were combined in toluene.  The flask was sealed, removed from the 
glove box and stirred at 60 °C for 18 hours.  The reaction was concentrated and purified by flash column 
chromatography (5% --> 20% Et2O/Pent). There were 3 bands that could be isolated from this column, first 2 
brown bands and then one green band.  The second brown band was the desired product; however, it was not 
completely pure after one column.  Recolumning in 10% Et2O/Pentane gave a brown oil product completely pure 
by 1H NMR (9 mg, 9%) and another fraction still slightly impure (18 mg, 18%). The products were lyophilized from 
benzene to give solids. 1H NMR (300 MHz, CDCl3) δ 16.78 (s, 1H), 8.13 (br, 2H), 7.74-7.62 (m, 4H), 7.07-7.04 (m, 
1H), 6.97 (dd, J = 3, 1.5 Hz, 1H), 6.66 (t, J = 7.5  Hz, 3H), 6.34 (d, J = 8.4 Hz, 1H), 4.49 (sept, J = 6 Hz, 1H), 1..44 
(d, J = 6 Hz, 6H), 1.44 (br, 18H), 1.18 (br, 18H); HRMS (EI+) calc for C41H56Cl2N2ORu, 764.2814. Found 
764.2842.   
 
 
Activity plots for 20. 
 
Preparation of stock solutions.  Catalyst 20 (9 mg) was placed in a 2ml volumetric flask and taken into a glove 
box.  In the glove box, 2ml of CD2Cl2 was added to make stock solution A.  0.33 ml of A was then transferred to 
another 2ml volumetric flask and diluted to 2ml with CD2Cl2 to make stock solution B. 
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In a glove box, 0.67 ml of stock solution A (3 mg of 20, 0.004 mmol) was transferred to a screw cap NMR tube.  
CD2Cl2 (.13 ml) was added and then 5 (21.5 µl, 0.08 mmol).   The NMR tube was sealed, removed from the glove 
box and heated to 30 °C.  A graph of conversion over time follows. 
RCM of 5 with 20 at 30 °C 
 
 
 
This experiment was repeated in C6D6 at 60 °C to examine the impact of temperature.  Catalyst 20 (3 mg, 0.004 
mmol) and C6D6 (.8 ml) were combined in a screw cap NMR tube and 5 (21.5 µl, 0.08 mmol) was added.  The 
NMR tube was sealed, removed from the glove box and heated to 60 °C.  A graph of conversion over time 
follows.  
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In a glove box, 0.8 ml of stock solution B (0.6 mg of 20, 0.0008 mmol) was transferred to a screw cap NMR tube.  
The NMR tube was sealed and transferred to a 500 MHz NMR which was warmed to 30 °C.  The NMR tube was 
then ejected,  S1 (20.5 µl, 0.08 mmol) was added and the tube was injected for data collection.  A graph of 
conversion over time follows. 
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In a glove box, 0.8 ml of stock solution B (0.6 mg of 20, 0.0008 mmol) was transferred to a screw cap NMR tube.  
The NMR tube was sealed and transferred to a 500 MHz NMR which was warmed to 30 °C.  The NMR tube was 
then ejected,  S3 (19.5 µl, 0.08 mmol) was added and the tube was injected for data collection.  A graph of 
conversion over time follows. 
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RCM of S3 with 20 at 30 °C 
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Ruthenium Catalyst 21.  In a glove box, diamine salt S24 (162 mg, .34 mmol), ruthenium precursor  
(PCy3)2(Cl)2Ru=CHPh (150 mg, .27 mmol) and KOt-Bu(F6) (74 mg, .34 mmol) were combined in C6D6 and stirred 
at RT for 2.5 hours.   The flask was sealed, removed from the glove box and the reaction was concentrated and 
purified by flash column chromatography (2.5% --> 5% Et2O/Pent) to yield a brown oil.  The brown oil was 
lyophilized from benzene to give a brown solid (66 mg, 25%). 1H NMR (300 MHz, CDCl3) δ 20.07 (d, J = 10.5 Hz, 
1H), 8.03 (br, 2H), 7.60 (t, 1.8 Hz, 1H), 6.86-6.81 (m, 2H), 6.51 - 6.47 (m, 1H), 1.81 - 1.07 (m). 
 
Standard activity plots for 21. 
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Preparation of stock solutions.  Catalyst 21 (11 mg) was placed in a 2ml volumetric flask and taken into a glove 
box.  In the glove box, 2ml of CD2Cl2 was added to make stock solution A.  0.4 ml of A was then transferred to 
another 2ml volumetric flask and diluted to 2ml with CD2Cl2 to make stock solution B. 
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In a glove box, 0.55 ml of stock solution A (3 mg of 3, 0.003 mmol) was transferred to a screw cap NMR tube.  
CD2Cl2 (.25 ml) was added and then 10 (21.5 µl, 0.08 mmol).   The NMR tube was sealed, removed from the 
glove box and heated to 30 °C.  A graph of conversion over time follows.  No further conversion is observed after 
2 hours. 
RCM of 5 with 21 at 30 °C 
 
 
 
This experiment was repeated in C6D6 at 60 °C to examine the impact of temperature.  Catalyst 21 (3 mg, 0.003 
mmol) and C6D6 (.8 ml) were combined in a screw cap NMR tube. The NMR tube was sealed and transferred to a 
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500 MHz NMR which was warmed to 60 °C.  The NMR tube was then ejected,  5 (21.5 µl, 0.08 mmol) was added 
and the tube was injected for data collection.  A graph of conversion over time follows. 
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In a glove box, 0.55 ml of stock solution B (0.6 mg of 21, 0.0008 mmol) was transferred to a screw cap NMR tube 
and 0.25 ml of CD2Cl2 was added.  The NMR tube was sealed and transferred to a 500 MHz NMR which was 
warmed to 30 °C.  The NMR tube was then ejected,  S1 (20.5 µl, 0.08 mmol) was added and the tube was 
injected for data collection.  A graph of conversion over time follows. 
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RCM of S1 with 21 at 30 °C 
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In a glove box, 0.55 ml of stock solution B (0.6 mg of 21, 0.0008 mmol) was transferred to a screw cap NMR tube 
and 0.25 ml of CD2Cl2 was added.  The NMR tube was sealed and transferred to a 500 MHz NMR which was 
warmed to 30 °C.  The NMR tube was then ejected,  S3 (19.5 µl, 0.08 mmol) was added and the tube was 
injected for data collection.  A graph of conversion over time follows.  
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RCM of S3 with 21 at 30 °C 
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Ruthenium Catalyst 22.  In a screw cap NMR tube, ruthenium compound 21 (10 mg, .01 mmol), 2-isopropoxy-3-
vinylbiphenyl  (5 mg, .02 mmol) and CuCl (1 mg, .01 mmol) were combined in CD2Cl2 (1 ml) in the glove box.  The 
reaction was heated at 40 °C for 29 hours, concentrated and purified by column chromatography (10% --> 25% 
Et2O/Pentange) to yield a grayish green oil.  This oil was lyophilized from benzene to yield a solid (2 mg, 25%).  
1H NMR (300 MHz, CDCl3) δ 16.77 (s, 1H), 7.89 (s, 1H), 7.66 - 7.59 (m, 6H), 7.50 - 7.38 (m, 7H), 7.02 (t, J = 4.5 
Hz, 1H), 6.72 (dd, J = 3.6, 1.2 Hz, 1H), 4.45 (sept, J = 3.6 Hz, 1H), 1.47 (s, 18H), 1.30 (s, 18H), 0.95 (d, J = 3.6 
Hz, 6H). 
 
Activity plot for 22. 
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In a glove box, catalyst 22 (2 mg, .002 mmol) was combined with CD2Cl2 (.4 ml) in a screw cap NMR tube. The 
NMR tube was sealed and transferred to a 500 MHz NMR which was warmed to 30 °C.  The NMR tube was then 
ejected,  5 (11 µl, 0.04 mmol) was added and the tube was injected for data collection. A graph of conversion 
over time follows. 
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Synthesis of RCM substrates.  
Br
S10 S11
+
NaH, THF, 60 °C
EtO OEt
O O
EtO OEt
O O
S12  
Preparation of Diethyl methallylmalonate S12. 
Diethyl methallylmalonate is a known compound: Begley, M. J.; Housden, N.; Johns, A.; Murphy, J. A. 
Tetrahedron 1991, 47, 8417, but we report our synthesis for convenience.  NaH (238 mg, 9.9 mmol) was 
suspended in THF (10 ml) and diethyl malonate (1.5 ml, 9.9 mmol) was added dropwise with vigorous bubbling 
observed.  3-bromo-2-methyl-propene (1 ml, 9.9 mmol) was added dropwise and the reaction was stirred at 60 °C 
for 24 hours.  The reaction was cooled to RT and quenched with water.  A copious amount of Et2O was added 
and the water layer was removed.  The organic fraction was dried with MgSO4, concentrated and purified by 
column chromatography (10% EtOAc/Hex) to yield 1.481g (70 %) of diethyl methallylmalonate (S12). 1H NMR 
(300 MHz, C6D6) δ 4.75 (d, J = 18 Hz, 2H), 4.19 (q, J = 6.9 Hz, 4H), 3.57 (t, J = 7.8 Hz), 2.61 (d, J = 7.8 Hz, 2H), 
1.74 (s, 3H), 1.26 (t, J = 7.2 Hz, 6H).  
 
EtO OEt
O O
S12
NaOEt, DMF
Cl
S13
+ RT
5
OO
EtO OEt
 
Preparation of Substrate 5. 
Substrate 5 was prepared from diethyl methallylmalonate (S12) as it has been prepared previously in our group: 
Kirkland, T. A.; Grubbs, R. H. J. Org. Chem. 1997, 62, 7310. 
 
EtO OEt
O O
S12
NaOEt, DMF
S14
+ RT
13
OO
EtO OEt
Br
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Preparation of Substrate 13. 
Substrate 13 was prepared from diethyl methallylmalonate (S12)  as it has been prepared previously in our group: 
Kirkland, T. A.; Grubbs, R. H. J. Org. Chem. 1997, 62, 7310. 
 
EtO OEt
O O
S10
NaH, THF
S14
+ 60 °C
S15
OO
EtO OEt
Br
 
Preparation of Diethyl 2-(3-methylbut-3-enyl)malonate S15. 
NaH (523 mg, 21.8 mmol) was suspended in THF (10ml) and diethyl malonate (1.5 ml, 9.9 mmol) was added 
dropwise with vigorous bubbling observed.  The reaction was heated to 60 °C and 4-bromo-2-methyl-1-butene3 
(2.33 ml, 21.8 mmol) was added dropwise.  The reaction was stirred for 20 hours, cooled to RT, quenched with 
water and copious Et2O was added.  The organic layer was separated, dried with MgSO4, concentrated and 
purified by column chromatography (5% EtOAc/Hex) to yield 715 mg (32%) of S15. 1H NMR (300 MHz, CDCl3) δ  
4.72 (d, J = 18 Hz, 2H), 4.19 (q, J = 7.2 Hz, 4H), 3.36-3.30 (m, 1H), 2.05-2.04 (m, 4H), 1.72 (s, 3H), 1.26 (t, J = 
7.2 Hz, 6H); 13C (75 MHz, CDCl3) δ 169.7, 144.3, 11.4, 61.6, 51.6, 35.5, 26.9, 22.4, 14.3. 
 
 
NaH, THF
S14
+ 60 °C
14
OO
EtO OEt
Br
S15
OO
EtO OEt
 
Preparation of substrate 14. 
NaH (82 mg, 3.4 mmol) was suspended in THF (5 ml) and S13 (715 mg, 3.1 mmol) was added dropwise.  The 
reaction was heated to 60 °C and vigorous bubbling was observed.  4-bromo-2-methyl-1-butene1 (336 µl, 3.1 
mmol) was added dropwise.  The reaction was stirred for 20 hours, cooled to RT, quenched with water and 
copious Et2O was added.  The organic layer was separated, dried with MgSO4, concentrated and purified by 
column chromatography (5% EtOAc/Hex) to yield 412 mg (45%) of 14. 1H NMR (300 MHz, C6D6) δ 4.76 (d, J = 
                                                      
3 Scholte, A. A.; Eubanks, L. M.; Poulter, C. D.; Vederas, J. C. Bioorg. MEd. Chem. 2004, 12, 763. 
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19.8, 4H), 3.93 (q, J = 7.2 Hz, 4H), 2.33-2.29 (m, 4H), 2.07-2.02 (m, 4H), 1.59 (s, 6H), 0.87 (t, J = 6.9 Hz, 6H); 13C 
(75 MHz, CDCl3) δ 171.3, 144.9, 110.7, 60.9, 57.4, 32.6, 31.2, 22.4, 14.0. HRMS (EI+) calc for C17H29O4, 
297.2066, found 297.2069. 
 
 
Br
S11
+
NaH, THF, 60 °C
S OO
NH2
N
Ts
15S15  
Preparation of substrate 15.  NaH (1.39 g, 58 mmol) was suspended in THF (130 ml) at 0 °C and p-
toluenesulfonamide (S15) (5 g, 29 mmol) was added in THF (10 ml).  The reaction was warmed to RT and heated 
to 60 °C, whereupon the reaction started to foam vigorously.  The reaction was cooled to RT and stirred for 15 
minutes. 3-bromo-2-methylpropene (8.8 ml, 87 mmol) was added in THF (10 ml) and the reaction was heated to 
60 °C again.  The reaction stirred for 24 hours and was then quenched with water.  The organic layer was 
removed, dried over MgSO4, concentrated, and purified by column chromatography (20% EtOAc/Hex) to yield 2 g 
(25 %) of diene 15. 1H NMR (300 MHz, CDCl3) δ 7.70 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.1, 2H), 4.81 (d, J = 24.6 
Hz, 4H), 3.70 (s, 4H), 2.42 (s, 3H), 1.60 (s, 6H); 13C (75 MHz, CDCl3) δ 143.3, 140.3, 137.7, 129.7, 127.5, 114.8, 
53.3, 21.8, 20.2. HRMS (EI+) calc for C15H22NO2S, 280.1371, found 280.1373. 
 
 
O
16  
Diene 16 was purchased from “Monomer and Polymer, and Dajac Labs”  and used as received. 
Br
+
OH
S16 S11
NaH, THF
60 °C
O
17  
Preparation of substrate 17.  NaH (264 mg, 11 mmol) was suspended in THF (10 ml) at 0 °C and 3-methylbut-
3-en-1-ol (S16) (1.11 ml, 11 mmol) was added dropwise. The solution bubbled and turned yellow.  The solution 
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was heated to 60 °C and 3-bromo-2-methylpropene (1ml, 9.9 mmol) was added.  The reaction was stirred for 48 
hours, cooled to RT and quenched with water.  The reaction was extracted 4 times with Et2O and the combined 
organic fractions were dried with MgSO4, concentrated and purified by column chromatography (5% Et2O/Pent).  
The column fractions were concentrated to 17 using a rotovap with an ice bath.  This gave 1.22 g (88%) of diene 
17. 1H NMR (300 MHz, CDCl3) δ 4.92 (d, J = 21.9, 2H), 4.75 (d, J = 12.9, 2H), 3.88 (s, 2H), 3.51 (t, J = 6.9 Hz, 
2H), 2.31 (t, J = 6.9 Hz, 2H), 1.74 (d, J = 6 Hz, 6H); 13C (75 MHz, CDCl3) δ 143.2, 142.6, 112.2, 11.7, 75.1, 68.7, 
38.1, 22.9, 19.7; HRMS (EI+) calc for C9H16O, 140.1201, found 140.1199. 
O
18
O
OH
O
+
EDC, DMAP, Et3N
CH2Cl2
 
Preparation of substrate 18. 3-methyl-3-buten-1-ol (853 mg, 9.9 mmol), methacrylic acid (853 mg, 9.9 mmol) 
and DMAP (120 mg, .99 mmol) were dissolved in CH2Cl2, the solution was cooled to 0 °C, flushed with argon, and 
EDC (1.898 mg, 9.9 mmol) was added.  Then Et3N (2.67 ml, 19.8 mmol) was added and the reaction was stirred 
for 24 hours.  Precipitates were observed and 50 ml of Et2O was added.  The solution was washed with water, 1N 
HCl, water and brine, dried over MgSO4, concentrated and purified by column chromatography (10% EtOAc/Hex) 
to yield 703 mg (46%) of substrate 18. 1H NMR (300 MHz, CDCl3) δ 6.09-6.08 (m, 1H), 5.54-5.53 (m, 1H), 4.80 (s, 
1H), 4.74 (s, 1H), 4.25 (t, J = 6.6 Hz, 2H), 2.37 (t, J = 6.6 Hz, 2H), 1.92 (s, 3H), 1.76 (s, 3H); 13C (75 MHz, CDCl3) 
δ 146.9, 142.0, 136.6, 125.6, 112.5, 63.1, 36.9, 22.7, 18.5; HRMS (EI+) calc for C9H14O2, 154.0994, found 
154.0994. 
 
OH
HO
O
+
EDC, DMAP, Et3N
CH2Cl2
O
O
S17 S18 19  
Preparation of substrate 19.  Primary alcohol S174 (747 mg, 4.78 mmol), carboxylic acid S18 (747 mg, 4.78 
mmol) and DMAP (58 mg, .478 mmol) were dissolved in CH2Cl2, the solution was cooled to 0 °C, flushed with 
argon, and EDC (916 mg, 4.78 mmol) was added.  Then Et3N (1.3 ml, 9.6 mmol) was added and the reaction was 
stirred for 24 hours.  Precipitates were observed and 50 ml of Et2O was added.  The solution was washed with 
water, 1N HCl, water and brine, dried over MgSO4, concentrated and purified by column chromatography (5% 
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EtOAc/Hex) to yield 1.115 g (83%) of substrate 19. 1H NMR (300 MHz, CDCl3) δ 4.66 (d, J = 8.7 Hz, 4H), 4.05 (t, 
J = 6.9 Hz, 2H), 2.29 (t, J = 7.5 Hz, 2H), 2.00 (t, J = 7.8 Hz, 2H), 1.70 (s, 6H), 1.68-1.28 (m, 14H); 13C (75 MHz, 
CDCl3) δ 148.0, 146.3, 146.2, 131.9, 110.0, 109.9, 64.6, 37.9, 37.8, 34.6, 29.1, 29.0, 28.8, 27.7, 27.4, 26.1, 25.1, 
22.6; HRMS (EI+) calc for C18H32O2, 280.2402, found 280.2390. 
 
RCM to form tetrasubstituted olefins using 3, 10, 11, 12. 
 
Standard RCM procedure for table 3. 
  For Conversions:  Catalyst 3, 12, or 11 (.02 mmol) was weighed into a 2 ml volumetric flask that was taken into 
the glove box.  C6D6 (2 ml) was added and then 0.4 ml of the solution (.004 mmol of catalyst) was transferred to a 
screw cap NMR tube.  The solution in the NMR tube was diluted with 0.4 ml of C6D6 and the tube was sealed with 
a screw cap that had a built in septa.  The NMR tube was removed from the glove box, the substrated (.08 mmol) 
was injected and the tube was heated to 60 °C in an oil bath.  After 24 hours, the tube was removed and an NMR 
was taken to determine conversion. 
 
Conversions for catalyst 10 were obtained using a slightly different procedure because 10 is insoluble in benzene.  
Instead, catalyst 10 (18.5 mg, .03 mmol) was dissolved in CDCl3 (5.92 ml) and then 0.8 ml of the solution (.004 
mmol of catalyst) was transferred to a screw cap NMR tube, which was sealed with a screw cap that had a built in 
septa.  The NMR tube was removed from the glove box, the substrated (.08 mmol) was injected and the tube was 
heated to 60 °C in an oil bath.  After 24 hours, the tube was removed and an NMR was taken to determine 
conversion. 
 
 
  For Isolated Yields:  Catalyst 12 (7 mg, .009 mmol) was weighed into a 1 dram vial .  A stirbar was added and 
the vial was taken into the glove box where C6D6 (1.8 ml) was added.  The vial was sealed with a screw cap that 
had a built in septa and removed from the box.  The substrate (0.185 mmol) was injected and the vial was heated 
to 60 °C in an oil bath.  After 24 hours, the solution was concentrated and the product was purified by column 
chromatography. 
                                                                                                                                                                                         
4 Taber, D. F.; Christos, T. E.; Neubert, T. D.; Batra, D. J. Org. Chem. 1999, 64, 9673. 
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5
OO
EtO OEt
catalyst (5 mol%)
solvent, 60 °C, 24h
OO
EtO OEt
6  
For Conversion: The SM methylene signal at 2.99 ppm was compared to the product signal at 3.14 ppm. 
For Isolated Yield: 50 µl of 5 was used. The rxn was columned in 5% EtOAc/Hex to yield 38.5 mg (86 %).  
Product 6 is a known compound and our spectral data matches the published data: Kirkland, T. A.; Grubbs, R. H. 
J. Org. Chem. 1997, 62, 7310. 
 
13
OO
EtO OEt
OEt
O
O
EtO
S19
catalyst (5 mol%)
solvent, 60 °C, 24h
 
For Conversion: The SM methylene signal at 2.72 ppm was compared to the product signal at 2.63 ppm. 
For Isolated Yield: 52 µl of 13 was used. The rxn was columned in 5% EtOAc/Hex to yield S19 quantitatively.  
Product S19 is a known compound and our spectral data matches the published data: Kirkland, T. A.; Grubbs, R. 
H. J. Org. Chem. 1997, 62, 7310. 
14
OO
EtO OEt
O O
EtO OEt
S20
catalyst (5 mol%)
solvent, 60 °C, 24h
 
For Conversion: The SM methyl group signal at 1.59 ppm was compared to the product signal at 1.50 ppm. 
For Isolated Yield: 55 µl of 14 was used. The rxn was columned in 5% EtOAc/Hex to yield 23 mg (47 %).  
Product S20 is a known compound and our spectral data matches the published data: Fürstner, A.; Thiel, O. R.; 
Ackermann, L.; Schanz, H.-J.; Nolan, S. P. J. Org. Chem. 2000, 65, 2204. 
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catalyst (5 mol%)
solvent, 60 °C, 24h
N
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S21  
For Conversion: The SM methyl group signal at 3.62 ppm was compared to the product signal at 3.84 ppm. 
For Isolated Yield: 52 µl of 15 was used. The rxn was columned in 25% EtOAc/Hex to yield S21 quantitatively.  
Product S21 is a known compound and our spectral data matches the published data: Arisawa, M.; Terada, Y.; 
Takahashi, K.; Nakagawa, M.; Nishida, A. J. Org. Chem. 2006, 71, 4255. 
O
16
catalyst (5 mol%)
solvent, 60 °C, 24h
O
S22  
For Conversion: The SM methylene signal at 3.68 ppm was compared to the product signal at 4.45 ppm. 
For Isolated Yield: Product S22 was not isolated due to its high volatility.  Product S22 is a known compound 
and our spectral data matches the published data:  Ripoll, J.-L. Tetrahedron Lett. 1974, 15, 1665. A 1H NMR is 
reported here for convenience: 1H NMR (300 MHz, CDCl3) δ 4.45 (s, 4H), 1.23 (s, 6H). 
O
17
catalyst (5 mol%)
solvent, 60 °C, 24h
O
S23  
For Conversion: The SM methylene signal at 3.51 ppm was compared to the product signal at 3.76 ppm.  The 
impurity has a signal at 4.26 ppm. 
For Isolated Yield: An isolated yield was not obtained for S23 due to its high volatility.    A sample was isolated 
by column chromatography (5% Et2O/Hex) but the solvent could not be fully removed for the 1H NMR so the 
methyl groups could not be rigorously identified. 1H NMR (300 MHz, CDCl3) δ 3.92 (s, 2H), 3.76 (t, J = 6 Hz, 2H), 
2.01 (s, 2H). 
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Spectra of novel compounds  
 
 
 
 
 
 
Figure SI.1: 1H NMR spectrum (300 Mz, CD2Cl2) of complex S7. 
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Figure SI.2: 13C NMR spectrum (75 Mz, CD2Cl2) of complex S7. 
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Figure SI.3: 1H NMR spectrum (300 Mz, CD2Cl2) of complex 11. 
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Figure SI.4: Partial 1H NMR spectrum (500 Mz, CD2Cl2) of complex 11 acquired at –30 ºC. An expansion of the 
aromatic region is shown. 
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Figure SI.5: 13C NMR spectrum (75 Mz, CD2Cl2) of complex 11. 
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